New York, United States, 2023-Oct-17 — /EPR Network/ —Transthyretin amyloidosis is a protein disorder where clumps of irregular protein known as fibrils build up in [read full pr… Read More
Pfizer Inc. (NYSE: PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas… Read More
The ‘Global Transthyretin Amyloidosis Treatment Market Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global transthyretin amyloidosis… Read More
Delveinsight Business Research LLP
As per DelveInsight’s assessment, globally, about 75+ key pharma and biotech companies are working on 80+ pipeline drugs in the Wet Age-Related Mac… Read More
Global Cyclophosphamide Drug Market Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global cyclophosphamide drug market share, assessing… Read More
The ‘Global Cyclophosphamide Drug Market Report and Forecast 2023-2031’ by Expert Market Research provides a comprehensive outlook on the global cyclophosphamide drug market… Read More
Existing research shows that nucleic acids can be used for the treatment of neurological diseases, cardiovascular diseases, and cancer, as well as for the prevention of chronic and infectiou… Read More
The ‘North America Vapour Barrier Market Size, Share, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the North America vapour barrier mark… Read More
Multiple Myeloma
92% was the overall response rate produced by NXC-201 in relapsed/refractory multiple myeloma patients treated at the therapeutic dose of 800 million CAR+T cells in its on… Read More
factor xi deficiency :: Article CreatorFactor X Deficiency Factor X deficiency is a condition caused by not enough of the protein factor X in your blood. This coa… Read More
Amiclear – The Blood Sugar Formula That Promises To Keep You Healthy
“Amiclear is a blood sugar formula that promises to keep you healthy. The makers of Amiclear&n… Read More
IONS (Ionis Pharmaceuticals, Inc.) SVB Leerink boosted their earnings-per-share expectations for Ionis Pharmaceuticals for the fourth quarter of 2022 in a research note published on Wednesda… Read More
On Thursday, November 3, before the opening of the stock market, Intellia Therapeutics (NASDAQ: NTLA) will announce the monetary outcomes of its most recent quarterly report. The majority op… Read More
Investors are facing a storm of headwinds right now – a genuine bear market, stubbornly high inflation, rising interest rates, and increased fears of a recession in the near-term… Read More
Text size
Intellia CEO John Leonard named the final results a vindication of the firm’s modular solution to Crispr therapies.
Courtesy Intel… Read More
With the continuous development of molecular biology technology, the relationship between gene mutations and diseases has gained more and more in-depth understanding. Nucleic acids have attr… Read More
In the latest issue of the JMC journal, a review article, entitled “A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions”, was published, which analyzed and s… Read More
Rolling NDA submission for CUTX-101 for the treatment of Menkes disease is expected to begin in the second half of 2021
On track to report top-line results from the registration-enabling… Read More
Biotech stocks headed higher in the week finished Dec. 5 as more extensive market hopefulness infested into the area. The area likewise kept on getting support from immunization related posi… Read More
Hans / Pixabay
The News:
Alnylam Pharmaceuticals Inc.’s (Cambridge MA) RNAi-based drug that targets a rare genetic disease cleared a key study, in a breakthrough for the new class of m… Read More
Boston, Massachusetts--(Newsfile Corp. - April 10, 2020) - Thornton Law Firm LLP, a law firm that represents shareholders in recovery actions, is investigating potential breach of fiduciary… Read More
The Burden of Alzheimer’s Disease
Almost everybody in the US has been affected by Alzheimer’s Disease. The Centers for Disease Control and Prevention (CDC) reports Alzheimer&rsqu… Read More
MasterTux / Pixabay
The healthcare stock market’s recent success is largely dependent on the fact that, as the global population increases and more people need access to healthcar… Read More
Prothena Corp (NDAQ:PRTA) Change of Rating
Prothena Corp (NDAQ:PRTA) was decreased by Wedbush from Outperform rating to Neutral rating in a research note issued to clients on Monday, 20 N… Read More
Analysts await BELLUS Health Inc (TSE:BLU) to reports earnings on March, 16. The stock decreased 1.71% or $0.03 on March 14, hitting $1.72. About 56,657 shares traded hands. BELLUS Health In… Read More